UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acoustic separation of circulating tumor cells

Proceedings of the National Academy of Sciences - PNAS, 2015-04, Vol.112 (16), p.4970-4975

2015

Volltextzugriff (PDF)

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1556-1563

2018

Volltextzugriff (PDF)

The exercise in all chemotherapy trial

Cancer, 2021-05, Vol.127 (9), p.1507-1516

2021

Volltextzugriff (PDF)

Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells

Clinical chemistry (Baltimore, Md.), 2014-02, Vol.60 (2), p.323-333

2014

Volltextzugriff (PDF)

Identification and Quantification of Novel Major Metabolites of the Steroidal Aromatase Inhibitor, Exemestane

Drug metabolism and disposition, 2018-12, Vol.46 (12), p.1867-1878

2018

Volltextzugriff (PDF)

Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer

Clinical cancer research, 2006-03, Vol.12 (5), p.1570-1576

2006

Volltextzugriff (PDF)

Predicting therapy response in live tumor cells isolated with the flexible micro spring array device

Cell cycle (Georgetown, Tex.), 2013-07, Vol.12 (13), p.2132-2143

2013

Volltextzugriff (PDF)

Challenges in the development of anti-epidermal growth factor receptor therapies in breast cancer

Seminars in oncology, 2004-02, Vol.31 (1 Suppl 3), p.3-8

2004

Volltextzugriff (PDF)

Hepatoid carcinoma of the ovary

Journal of clinical oncology, 2011-05, Vol.29 (15), p.e446-e448

2011

Volltextzugriff (PDF)

A First Step To Enhance Step Counts In Women With Metastatic Breast Cancer: An Exploratory Study: 862

Medicine and science in sports and exercise, 2023-09, Vol.55 (9S), p.304-304

2023

Volltextzugriff (PDF)

A phase II, single-arm, non-randomized study of alpelisib (BYL719) in combination with continued endocrine therapy following progression on endocrine therapy in hormone receptor–positive, HER2-negative, PIK3CA- mutant metastatic breast cancer: A Big Ten Cancer Research Consortium Study (btcrc-BRE19-409)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS1114-TPS1114

2022

Volltextzugriff (PDF)

Abstract PO2-19-04: Trial in Progress: The REJOIN Trial to Use Exercise and Education to Relieve Joint Pain in Older Breast Cancer Survivors Taking Aromatase Inhibitors

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO2-19-04-PO2-19-04

2024

Volltextzugriff (PDF)

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

The New England journal of medicine, 2015-03, Vol.372 (10), p.944-953

2015

Volltextzugriff (PDF)

Nurse AMIE: Addressing symptoms in rural patients with advanced cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS12148-TPS12148

2022

Volltextzugriff (PDF)

Identification of exosome protein biomarkers in patients with advanced hormone receptor-positive breast cancer treated with palbociclib and tamoxifen

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13014-e13014

2022

Volltextzugriff (PDF)

Role of the UGT2B17 deletion in exemestane pharmacogenetics

The pharmacogenomics journal, 2018-04, Vol.18 (2), p.295-300

2018

Volltextzugriff (PDF)

Deep proteomic analysis of plasma exosomes in patients with advanced, hormone receptor-positive breast cancer treated with palbociclib and tamoxifen

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1030-1030

2021

Volltextzugriff (PDF)

A single-arm phase II trial of palbociclib in combination with tamoxifen as first-line therapy for metastatic hormone receptor-positive breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1056-1056

2021

Volltextzugriff (PDF)

Circulating tumor cells in patients with hormone receptor-positive, HER2-negative metastatic breast cancer receiving palbociclib with fulvestrant after progression on palbociclib with an aromatase inhibitor

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13018-e13018

2023

Volltextzugriff (PDF)

Abstract P1-19-30: Safety results from a phase 2 study of Palbociclib in combination with Tamoxifen as first line therapy for metastatic hormone receptor positive breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-19-30

2020

Volltextzugriff (PDF)

UGT2B17 deletion polymorphism and exemestane-induced toxicity

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12534-e12534

2018

Volltextzugriff (PDF)

β-catenin affects androgen receptor transcriptional activity and ligand specificity

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (17), p.4709-4713

2000

Volltextzugriff (PDF)

Write to recover: The impact of group led creative writing on behavioral health outcomes in cancer patients

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.11536-11536

2019

Volltextzugriff (PDF)

Abstract P5-13-10: Elevated plasma IL-8 predicts for reduced outcomes in CCTG MA.38, a phase 2 randomized trial of palbociclib in ER+/HER2- metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-13-10

2022

Volltextzugriff (PDF)

Effect of creative writing on mood in cancer patients

Journal of clinical oncology, 2017-11, Vol.35 (31_suppl), p.178-178

2017

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionDe Gruyter journals

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Humans
(12)
Female
(8)
Oncology
(8)
Middle Aged
(6)
Tumors
(6)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Aged
(4)
Breast Neoplasms - Drug Therapy
(4)
Adult
(3)
Aged, 80 And Over
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Breast Cancer
(3)
Cell Separation - Methods
(3)
Cell Survival
(3)
Gynecology. Andrology. Obstetrics
(3)
Male
(3)
Patients
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acoustic separation of circulating tumor cells

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

The exercise in all chemotherapy trial

Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells

Identification and Quantification of Novel Major Metabolites of the Steroidal Aromatase Inhibitor, Exemestane

Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer

Predicting therapy response in live tumor cells isolated with the flexible micro spring array device

Challenges in the development of anti-epidermal growth factor receptor therapies in breast cancer

Hepatoid carcinoma of the ovary

A First Step To Enhance Step Counts In Women With Metastatic Breast Cancer: An Exploratory Study: 862

Abstract PO2-19-04: Trial in Progress: The REJOIN Trial to Use Exercise and Education to Relieve Joint Pain in Older Breast Cancer Survivors Taking Aromatase Inhibitors

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

Nurse AMIE: Addressing symptoms in rural patients with advanced cancer

Identification of exosome protein biomarkers in patients with advanced hormone receptor-positive breast cancer treated with palbociclib and tamoxifen

Role of the UGT2B17 deletion in exemestane pharmacogenetics

Deep proteomic analysis of plasma exosomes in patients with advanced, hormone receptor-positive breast cancer treated with palbociclib and tamoxifen

A single-arm phase II trial of palbociclib in combination with tamoxifen as first-line therapy for metastatic hormone receptor-positive breast cancer

Circulating tumor cells in patients with hormone receptor-positive, HER2-negative metastatic breast cancer receiving palbociclib with fulvestrant after progression on palbociclib with an aromatase inhibitor

Abstract P1-19-30: Safety results from a phase 2 study of Palbociclib in combination with Tamoxifen as first line therapy for metastatic hormone receptor positive breast cancer

UGT2B17 deletion polymorphism and exemestane-induced toxicity

β-catenin affects androgen receptor transcriptional activity and ligand specificity

Write to recover: The impact of group led creative writing on behavioral health outcomes in cancer patients

Abstract P5-13-10: Elevated plasma IL-8 predicts for reduced outcomes in CCTG MA.38, a phase 2 randomized trial of palbociclib in ER+/HER2- metastatic breast cancer patients

Effect of creative writing on mood in cancer patients

Aktive Filter

Suchergebnisse filtern